TALECRIS VISION
CORPORATE SITES
Talecris Europe
Talecris United States
Talecris Corporate
View All
PRODUCT SITES
Alpha-1 Antitrypsin Deficiency
(Prolastin/Prolastina)
Immune Globulin Intravenous
Therapy
(IGIV) (Gamunex)
Human Albumin Products
(Plasbumin / Plasmanate)
Hyperimmune Globulin Therapy
(Hypermunes)
View All
PROGRAMS & SERVICES
Contract Manufacturing Services
CONTACT TALECRIS
Canada |
En Français
Home
About Talecris Canada
Our Products
Patient Advocacy
Media Center
Media Center
Media Center
If you are a member of the media and would like to speak to someone in our corporate headquarters Corporate Communications department, please call our media line at
(+1)919-316-6316
.
Inquiries from journalists only please.
PRESS RELEASES
May 14, 2008
Talecris Announces 2008 Application Cycle for Talents Research Grants, Presents 2007 Grant Awardees
May 08, 2007
Talecris Biotherapeutics’ Talents Program Accepting Applications for 2007 Research Grant Awards
May 03, 2007
Talecris Provides Educational Grant to Support World Federation of Hemophilia’s Global Laboratory Science Program
December 01, 2006
Talecris Continues Global Expansion into Europe
May 03, 2006
Talecris Biotherapeutics Launches Talents: Talecris New Trials Support Program
Contact Talecris
Glossary
Site Map
General Conditions of Use
Privacy Statement
© 2008 Talecris Biotherapeutics
